Furthermore, another study reported that both patients (2/2) with TP53 mutations progressed to DLBCL, whereas none of the 43 patients with TP53 wild-type experienced transformation [29,31]. This evidence concerns the gene TP53 and diffuse large B-cell lymphoma.